Bamco Inc Dexcom Inc Transaction History

Bamco Inc

$35.5 Billion
Q3 2025

A detailed history of Bamco Inc transactions in Dexcom Inc stock. As of the latest transaction made, Bamco Inc holds 272,500 shares of DXCM stock, worth $15.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

272,500

Previous 332,500 18.05%

Holding current value

$15.8 Million

Previous $29 Million 36.82%

% of portfolio

0.05%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$66.46 - $89.53 $3.99 Million - $5.37 Million	-60,000 Reduced 18.05%	272,500 $18.3 Million
Q2 2025 Aug 14, 2025	SELL	$59.83 - $87.57 $5.98 Million - $8.76 Million	-100,000 Reduced 23.12%	332,500 $29 Million
Q4 2024 Feb 14, 2025	SELL	$65.68 - $81.01 $8.69 Million - $10.7 Million	-132,354 Reduced 23.43%	432,500 $33.6 Million
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $25.7 Million - $46.6 Million	-401,618 Reduced 41.56%	564,854 $37.9 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $166,678 - $212,219	-1,511 Reduced 0.16%	966,472 $110 Million

Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $3.4 Million - $4.16 Million	-29,725 Reduced 2.98%	967,983 $134 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $24.3 Million - $39.9 Million	-321,358 Reduced 24.36%	997,708 $124 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $9.29 Million - $14.9 Million	-107,924 Reduced 7.56%	1,319,066 $123 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $1.14 Million - $1.33 Million	-10,150 Reduced 0.71%	1,426,990 $183 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $8.48 Million - $10 Million	81,553 Added 6.02%	1,437,140 $167 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $9.79 Million - $14.1 Million	-115,159 Reduced 7.83%	1,355,587 $154 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $51,307 - $63,288	672 Added 0.05%	1,470,746 $118 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $74.8 Million - $146 Million	1,100,105 Added 297.35%	1,470,074 $110 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $1.03 Million - $1.42 Million	-10,919 Reduced 2.87%	369,969 $189 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $2.38 Million - $2.99 Million	-18,358 Reduced 4.6%	380,888 $205 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $322,264 - $432,403	3,020 Added 0.76%	399,246 $218 Million
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $1.56 Million - $2.08 Million	-19,311 Reduced 4.65%	396,226 $169 Million
Q1 2021 May 19, 2021	SELL	$84.79 - $104.74 $84,111 - $103,902	-992 Reduced 0.24%	415,537 $149 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $5,226 - $7,001	-67 Reduced 0.02%	416,529 $154 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $5.26 Million - $6.22 Million	-55,080 Reduced 11.68%	416,596 $172 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $1.77 Million - $2.97 Million	-28,168 Reduced 5.64%	471,676 $191 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $408,126 - $645,880	-8,540 Reduced 1.68%	499,844 $135 Million
Q4 2019 Feb 18, 2020	BUY	$36.62 - $57.29 $17,248 - $26,983	471 Added 0.09%	508,384 $111 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $272,479 - $335,902	7,669 Added 1.53%	507,913 $75.8 Million
Q2 2019 Aug 15, 2019	BUY	$27.84 - $38.92 $2.4 Million - $3.36 Million	86,347 Added 20.86%	500,244 $75 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $3.14 Million - $4.27 Million	111,916 Added 37.06%	413,897 $49.3 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $8,636 - $11,958	320 Added 0.11%	301,981 $36.2 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $15,434 - $24,271	661 Added 0.22%	301,661 $43.2 Million
Q3 2017 Nov 15, 2017	BUY	$11.36 - $18.98 $3.42 Million - $5.71 Million	301,000	301,000 $14.7 Million

Others Institutions Holding DXCM

# of Institutions

1,090

Shares Held

445M

Call Options Held

6.78M

Put Options Held

7.25M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account